Portfolio company
AC Immune
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops therapeutic and diagnostic candidates for neurodegenerative diseases, providing precision medicine solutions to patients, healthcare providers, and pharmaceutical partners.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Kalgene
This biotechnology company develops precision medicine therapeutics and companion diagnostics to treat Alzheimer's disease and various cancers for patients and clinical providers.
Bioarctic Biociences
This biopharmaceutical company develops antibody-based disease-modifying treatments for neurodegenerative disorders, such as Alzheimer's and Parkinson's, for healthcare providers and patients.
aprinoia
This biopharmaceutical company develops diagnostic tools and targeted therapeutics for neurodegenerative diseases to serve healthcare providers and patients.
Alzinova
This biopharmaceutical company develops immunotherapies and vaccines targeting toxic amyloid-beta oligomers to treat and prevent Alzheimer's disease for patients worldwide.
Muna Therapeutics
This biopharmaceutical company develops small-molecule therapeutics to treat neurodegenerative diseases, such as Alzheimer's and Parkinson's, for patients and healthcare providers.
Acumen Pharmaceuticals
This biopharmaceutical company develops novel targeted therapies for patients with Alzheimer's disease by targeting toxic soluble amyloid beta oligomers.
Alzeca Biosciences
This company develops MRI contrast agents to enable early diagnosis of Alzheimer's disease and other neurodegenerative disorders for healthcare providers and clinical researchers.
MindImmune
This pharmaceutical company develops immunomodulatory monoclonal antibodies to treat patients suffering from neurodegenerative diseases like Alzheimer's by targeting brain inflammation.
